Hoth Therapeutics Inc (NASDAQ:HOTH) Climbs 65.62% In 2025; Is It Attractive Enough At $1.53?

In last trading session, Hoth Therapeutics Inc (NASDAQ:HOTH) saw 29.5 million shares changing hands with its beta currently measuring 0.55. Company’s recent per share price level of $1.53 trading at $0.61 or 66.34% at ring of the bell on the day assigns it a market valuation of $20.21M. That closing price of HOTH’s stock is at a discount of -148.37% from its 52-week high price of $3.80 and is indicating a premium of 62.09% from its 52-week low price of $0.58. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.12 million shares which gives us an average trading volume of 602.33K if we extend that period to 3-months.

For Hoth Therapeutics Inc (HOTH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Hoth Therapeutics Inc (NASDAQ:HOTH) trade information

Hoth Therapeutics Inc’s shares saw a change of 104.52% in year-to-date performance and have moved 80.57% in past 5-day. Hoth Therapeutics Inc (NASDAQ:HOTH) showed a performance of 76.13% in past 30-days. Number of shares sold short was 0.2 million shares which calculate 0.77 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 27.96% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 65.62% while estimates for its earnings growth in next 5 years are of 26.90%.

Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders

Insiders are in possession of 0.50% of company’s total shares while institution are holding 2.31 percent of that, with stock having share float percentage of 2.32%. Investors also watch the number of corporate investors in a company very closely, which is 2.31% institutions for Hoth Therapeutics Inc that are currently holding shares of the company. ARMISTICE CAPITAL, LLC is the top institutional holder at HOTH for having 0.21 million shares of worth $0.19 million. And as of 2024-06-30, it was holding 3.0976 of the company’s outstanding shares.

The second largest institutional holder is MORGAN STANLEY, which was holding about 10008.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.1455 of outstanding shares, having a total worth of $9100.0.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 41.49 shares of worth $63479.0 or 0.31% of the total outstanding shares. The later fund manager was in possession of 38.8 shares on Mar 31, 2025 , making its stake of worth around $59370.0 in the company or a holder of 0.29% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.